Invirase Unjoni Ewropea - Malti - EMA (European Medicines Agency)

invirase

roche registration gmbh - saquinavir - infezzjonijiet ta 'hiv - antivirali għal użu sistemiku - invirase huwa indikat għall-kura ta 'pazjenti adulti infettati bl-hiv-1. invirase għandu jingħata biss flimkien ma 'ritonavir u prodotti mediċinali antiretrovirali oħra.

Rydapt Unjoni Ewropea - Malti - EMA (European Medicines Agency)

rydapt

novartis europharm ltd - midostaurin - leukemia, myeloid, acute; mastocytosis - aġenti antineoplastiċi - rydapt huwa indikat:f'kombinazzjoni mal-istandard daunorubicin u cytarabine induzzjoni u doża għolja ta ' cytarabine konsolidazzjoni kimoterapija, u għall-pazjenti fil-rispons sħiħ segwit minn rydapt waħidha-manutenzjoni tal-kura, għall-pazjenti adulti li jkunu għadhom kif ġew dijanjostikati lewkimja majelojde akuta (aml) li huma flt3 mutazzjoni pożittivi (ara sezzjoni 4. 2);bħala monoterapija għall-kura ta ' pazjenti adulti b'aggressiva sistemika mastocytosis (asm), sistemika mastocytosis assoċjati mal-ematoloġiċi neoplażmi (sm ahn), jew tal-mast cell li lewkimja (mcl).

Dimethyl fumarate Neuraxpharm Unjoni Ewropea - Malti - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetil fumarate - l-isklerożi multipla, sklerożi multipla li tirkadi u tbatti - immunosoppressanti - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Pregabalin Accord Unjoni Ewropea - Malti - EMA (European Medicines Agency)

pregabalin accord

accord healthcare s.l.u. - pregabalin - anxiety disorders; epilepsy - anti-epilettiċi, - epilepsypregabalin qbil huwa indikat bħala terapija aġġuntiva f'persuni adulti b'aċċessjonijiet parzjali bi jew mingħajr ġeneralizzazzjoni sekondarja. ta'ansjetà ġeneralizzata disorderpregabalin qbil huwa indikat għall-kura ta 'disturb ta' ansjetà Ġeneralizzata (gad-generalised anxiety disorder) f'persuni adulti.

Xermelo Unjoni Ewropea - Malti - EMA (European Medicines Agency)

xermelo

serb sas - telotristat ettabate - carcinoid tumor; neuroendocrine tumors - prodotti oħra alimentari u metaboliżmu - xermelo huwa indikat għat-trattament ta 'dijarrea tas-sindrome karċinojde flimkien ma' terapija analoga ta 'somatostatin (ssa) f'adulti li mhumiex ikkontrollati b'mod adegwat minn terapija ssa.

Xenleta Unjoni Ewropea - Malti - EMA (European Medicines Agency)

xenleta

nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - antibatteriċi għal użu sistemiku, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. għandha tingħata kunsiderazzjoni għall-gwida uffiċjali dwar l-użu xieraq ta ' sustanzi antibatteriċi.

Luveris Unjoni Ewropea - Malti - EMA (European Medicines Agency)

luveris

merck europe b.v.  - lutropin alfa - ovulation induction; infertility, female - - ormoni tas-sess u modulaturi ta ' l-ġenitali-sistema, - luveris fl-assoċjazzjoni mal-preparazzjoni (fsh) follicle-istimulazzjoni-ormoni huwa rakkomandat għall-istimulazzjoni ta ' l-iżvilupp follicular fin-nisa ma severi luteinising-ormoni (lh) u fsh defiċjenza. fi provi kliniċi, dawn il-pazjenti ġew definiti bil-livelli endoġeni tas-serum lh.

Isturisa Unjoni Ewropea - Malti - EMA (European Medicines Agency)

isturisa

recordati rare diseases - osilodrostat phosphate - is-sindromu ta 'cushing - kortikosterojdi għal użu sistemiku - isturisa huwa indikat għall-kura ta ' l-sindromu ta'cushing fl-adulti.

Bemfola Unjoni Ewropea - Malti - EMA (European Medicines Agency)

bemfola

gedeon richter plc. - follitropin alfa - anovulazzjoni - - ormoni tas-sess u modulaturi ta ' l-ġenitali-sistema, - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. fi provi kliniċi dawn il-pazjenti ġew definiti bil-livelli endoġeni tas-serum lh < 1. 2 iu / l. in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.

Ganirelix Gedeon Richter Unjoni Ewropea - Malti - EMA (European Medicines Agency)

ganirelix gedeon richter

chemical works of gedeon richter plc. (gedeon richter plc.) - ganirelix acetate - reproductive techniques, assisted; ovulation induction; infertility, female - ormoni u analogi pitwitarji u ipotalamiċi - prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation (coh) for assisted reproduction techniques (art).